183 related articles for article (PubMed ID: 20883178)
21. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
22. Chitosan-hyaluronic acid nanoparticles for gene silencing: the role of hyaluronic acid on the nanoparticles' formation and activity.
Al-Qadi S; Alatorre-Meda M; Zaghloul EM; Taboada P; Remunán-López C
Colloids Surf B Biointerfaces; 2013 Mar; 103():615-23. PubMed ID: 23274155
[TBL] [Abstract][Full Text] [Related]
23. Injectable and tunable hyaluronic acid hydrogels releasing chemotactic and angiogenic growth factors for endodontic regeneration.
Silva CR; Babo PS; Gulino M; Costa L; Oliveira JM; Silva-Correia J; Domingues RMA; Reis RL; Gomes ME
Acta Biomater; 2018 Sep; 77():155-171. PubMed ID: 30031163
[TBL] [Abstract][Full Text] [Related]
24. Heparinized collagen sutures for sustained delivery of PDGF-BB: Delivery profile and effects on tendon-derived cells In-Vitro.
Younesi M; Donmez BO; Islam A; Akkus O
Acta Biomater; 2016 Sep; 41():100-9. PubMed ID: 27240725
[TBL] [Abstract][Full Text] [Related]
25. Regulation of sequential release of growth factors using bilayer polymeric nanoparticles for cardiac tissue engineering.
Izadifar M; Kelly ME; Chen X
Nanomedicine (Lond); 2016 Dec; 11(24):3237-3259. PubMed ID: 27854552
[TBL] [Abstract][Full Text] [Related]
26. Effect of preparation parameters on ultra low molecular weight chitosan/hyaluronic acid nanoparticles.
Nazeri N; Avadi MR; Faramarzi MA; Safarian S; Tavoosidana G; Khoshayand MR; Amani A
Int J Biol Macromol; 2013 Nov; 62():642-6. PubMed ID: 24099942
[TBL] [Abstract][Full Text] [Related]
27. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
[TBL] [Abstract][Full Text] [Related]
28. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
[TBL] [Abstract][Full Text] [Related]
29. Sustained release of platelet-derived growth factor and vascular endothelial growth factor from silk/calcium phosphate/PLGA based nanocomposite scaffold.
Farokhi M; Mottaghitalab F; Ai J; Shokrgozar MA
Int J Pharm; 2013 Sep; 454(1):216-25. PubMed ID: 23856159
[TBL] [Abstract][Full Text] [Related]
30. Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells.
Almutairi FM; Abd-Rabou AA; Mohamed MS
Bioorg Med Chem; 2019 Apr; 27(8):1629-1638. PubMed ID: 30879864
[TBL] [Abstract][Full Text] [Related]
31. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
32. Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration.
Park YJ; Lee YM; Lee JY; Seol YJ; Chung CP; Lee SJ
J Control Release; 2000 Jul; 67(2-3):385-94. PubMed ID: 10825569
[TBL] [Abstract][Full Text] [Related]
33. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
de la Fuente M; Seijo B; Alonso MJ
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2016-24. PubMed ID: 18436835
[TBL] [Abstract][Full Text] [Related]
34. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.
Lu HD; Zhao HQ; Wang K; Lv LL
Int J Pharm; 2011 Nov; 420(2):358-65. PubMed ID: 21911044
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of platelet-derived growth factor-BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure.
Takayama H; Miyake Y; Nouso K; Ikeda F; Shiraha H; Takaki A; Kobashi H; Yamamoto K
J Gastroenterol Hepatol; 2011 Jan; 26(1):116-21. PubMed ID: 21175804
[TBL] [Abstract][Full Text] [Related]
36. Enzymatic in situ formed hydrogel from gelatin-tyramine and chitosan-4-hydroxylphenyl acetamide for the co-delivery of human adipose-derived stem cells and platelet-derived growth factor towards vascularization.
Linh NT; Abueva CD; Lee BT
Biomed Mater; 2017 Feb; 12(1):015026. PubMed ID: 28233762
[TBL] [Abstract][Full Text] [Related]
37. Accelerated and Improved Vascular Maturity after Transplantation of Testicular Tissue in Hydrogels Supplemented with VEGF- and PDGF-Loaded Nanoparticles.
Del Vento F; Poels J; Vermeulen M; Ucakar B; Giudice MG; Kanbar M; des Rieux A; Wyns C
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071329
[TBL] [Abstract][Full Text] [Related]
38. The early effects of sustained platelet-derived growth factor administration on the functional and structural properties of repaired intrasynovial flexor tendons: an in vivo biomechanic study at 3 weeks in canines.
Gelberman RH; Thomopoulos S; Sakiyama-Elbert SE; Das R; Silva MJ
J Hand Surg Am; 2007 Mar; 32(3):373-9. PubMed ID: 17336846
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB.
Banfi A; von Degenfeld G; Gianni-Barrera R; Reginato S; Merchant MJ; McDonald DM; Blau HM
FASEB J; 2012 Jun; 26(6):2486-97. PubMed ID: 22391130
[TBL] [Abstract][Full Text] [Related]
40. Platelet-derived growth factor enhancement of two alloplastic bone matrices.
Bateman J; Intini G; Margarone J; Goodloe S; Bush P; Lynch SE; Dziak R
J Periodontol; 2005 Nov; 76(11):1833-41. PubMed ID: 16274301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
